46
Podcast

How to Survive FDA Battles and Boardroom Drama - with Sabine Bois

This episode of the Crux of Medtech features Sabine Bois, the former CEO of Occlutech. Sabine is a medtech leader whose career spans founding startups, steering a company through bankruptcy, driving IPO prep, and ultimately leading as CEO. Her story is raw, unfiltered, and filled with lessons about resilience, leadership, and navigating the brutal realities of MedTech.

How to Survive FDA Battles and Boardroom Drama - with Sabine Bois

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
How to Survive FDA Battles and Boardroom Drama

Sabine Bois

Why MedTech Can’t Afford to Move Slow: Rethinking Healthcare’s Culture of Caution

Healthcare is built on caution, but has the pendulum swung too far? Discover why MedTech innovation needs a new balance between safety and speed - and how patients stand to benefit most.

Introduction

Healthcare innovation moves at a different pace than technology or AI - and for good reason. When lives are at stake, “move fast and break things” doesn’t apply. But has the culture of caution gone too far? In this episode of the Cruxx Podcast, our guests unpack the tension between safety and speed in MedTech, exploring why patients ultimately pay the price when innovation drags.


The Risk–Reward Curve in Healthcare

Unlike internet or AI companies, healthcare operates on a far stricter risk–reward curve. Mistakes can’t be patched with a software update - they can have real-world consequences for patients. This built-in caution is not only expected, it’s essential.

But here’s the catch: too much caution slows down adoption of promising technologies. And in a field where time equals lives, the risk of doing nothing can be just as great as the risk of moving too quickly.


When Safety Culture Becomes “Check-the-Box”

As one speaker explains, healthcare has drifted into a culture of cover-your-assets decision-making. Instead of pushing innovation, many organizations default to legacy processes simply because “it’s always been done this way.”

This protects institutions from blame - but it also entrenches slow progress. The result? Patients who could benefit from faster access to breakthrough technology are left waiting.


Patients as Stakeholders in Speed

The conversation emphasizes that the risk–reward curve doesn’t just belong to regulators or corporations - it belongs to patients, too. While organizations see risk in moving fast, patients often see risk in moving too slow. For someone waiting for treatment or a life-changing device, innovation delayed is opportunity denied.


Rethinking the Balance

The healthcare industry doesn’t need to abandon caution - but it does need to recalibrate. Moving forward means building systems that encourage innovation without compromising patient safety. That’s the only way MedTech can truly deliver on its promise: better outcomes, faster.


Conclusion & Call to Action

The Cruxx Podcast challenges the status quo: if innovation is possible, why let outdated caution stand in the way? It’s time to rethink the culture of healthcare and design a future where patients benefit from speed, without sacrificing safety.

👉 Listen to the full episode for deeper insights into MedTech’s risk–reward balance.

 

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

Discover more about Medical Devices